Sinopharm Rongsheng Receives NMPA Approval for Hypertension Drug Bisoprolol Amlodipine Tablets

Sinopharm Modern's wholly owned subsidiary Sinopharm Rongsheng has received the Drug Registration Certificate for bisoprolol amlodipine tablets, approved and issued by the National Medical Products Administration. The drug is intended as a replacement therapy for hypertension and is suitable for patients who are currently taking the same doses of the individual monotherapies as the combination product and whose blood pressure is well controlled.